Benzinga | Feb 16, 2021 09:40AM EST

NantKwest Announces Entered Into Agreement With ImmunityBio To Combine In A Stock-For-Stock Transaction

ImmunityBio separately announced today that it has entered into an agreement to combine in a stock-for-stock transaction with NantKwest, Inc. (( http://www.w3.org/1999/xhtml" rel="nofollow" href=" https://cts.businesswire.com/ct/CT?id=smartlink&, url=https%3A%2F%2Fwww.nasdaq.com%2Fmarket-activity%2Fstocks%2Fnk&, esheet=52379478&, newsitemid=20210216005447&, lan=en-US&, anchor=NASDAQ%3A+NK&, index=3&, NASDAQ:NK). The combination will create a leading immunotherapy and cell therapy companies focused on oncology and infectious disease.